Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Notable companies reporting after market close » 13:40
10/21/20
10/21
13:40
10/21/20
13:40
TSLA

Tesla

$428.60 /

+6.63 (+1.57%)

, CSX

CSX

$79.02 /

-1.13 (-1.41%)

, LRCX

Lam Research

$368.57 /

+4.72 (+1.30%)

, EW

Edwards Lifesciences

$83.07 /

-1.43 (-1.69%)

, CMG

Chipotle

$1,345.98 /

-2.91 (-0.22%)

, LVS

Las Vegas Sands

$46.10 /

-0.12 (-0.26%)

, KMI

Kinder Morgan

$12.51 /

-0.165 (-1.30%)

, XLNX

Xilinx

$112.17 /

-2.75 (-2.39%)

, ALGN

Align Technology

$334.03 /

-1.02 (-0.30%)

, EFX

Equifax

$162.59 /

+2.78 (+1.74%)

, DFS

Discover

$61.21 /

-1.75 (-2.78%)

, SLM

Sallie Mae

$9.34 /

-0.1 (-1.06%)

, STL

Sterling Bancorp

$12.27 /

-0.035 (-0.28%)

Notable companies…

Notable companies reporting after the market close, with earnings consensus, include Tesla (TSLA), consensus 56c... CSX Corp. (CSX), consensus 92c... Lam Research (LRCX), consensus $5.19... Edwards Lifesciences (EW), consensus 44C... Chipotle Mexican Grill (CMG), consensus $3.40... Las Vegas Sands (LVS), consensus (59c)... Kinder Morgan (KMI), consensus 21c... Xilinx (XLNX), consensus 74c... Align Technology (ALGN), consensus 54c... Equifax (EFX), consensus $1.60... Discover (DFS), consensus $1.53... SLM Corp (SLM), consensus 8c... Sterling Bancorp (STL), consensus 39c.

ShowHide Related Items >><<
TSLA Tesla
$428.60 /

+6.63 (+1.57%)

CSX CSX
$79.02 /

-1.13 (-1.41%)

LRCX Lam Research
$368.57 /

+4.72 (+1.30%)

EW Edwards Lifesciences
$83.07 /

-1.43 (-1.69%)

CMG Chipotle
$1,345.98 /

-2.91 (-0.22%)

LVS Las Vegas Sands
$46.10 /

-0.12 (-0.26%)

KMI Kinder Morgan
$12.51 /

-0.165 (-1.30%)

XLNX Xilinx
$112.17 /

-2.75 (-2.39%)

ALGN Align Technology
$334.03 /

-1.02 (-0.30%)

EFX Equifax
$162.59 /

+2.78 (+1.74%)

DFS Discover
$61.21 /

-1.75 (-2.78%)

SLM Sallie Mae
$9.34 /

-0.1 (-1.06%)

STL Sterling Bancorp
$12.27 /

-0.035 (-0.28%)

TSLA Tesla
$428.60 /

+6.63 (+1.57%)

10/19/20 Wedbush
Tesla price target raised to $500 from $475 at Wedbush
10/16/20 Morgan Stanley
Tesla price target raised to $333 from $272 at Morgan Stanley
10/14/20 Credit Suisse
Q3 beat could be positive catalyst for Tesla stock, says Credit Suisse
10/14/20 JPMorgan
NIO Inc. upgraded to Overweight from Neutral at JPMorgan
CSX CSX
$79.02 /

-1.13 (-1.41%)

10/16/20 Barclays
CSX price target raised to $92 from $78 at Barclays
10/13/20 Bernstein
CSX upgraded to Outperform at Bernstein on industry return to sustainable growth
10/12/20 Bernstein
CSX upgraded to Outperform from Market Perform at Bernstein
10/06/20 Susquehanna
Susquehanna sees highest returns in Eastern rails
LRCX Lam Research
$368.57 /

+4.72 (+1.30%)

09/25/20 Citi
KLA on top, Amkor at bottom of Citi's Semiconductor rankings
09/20/20 Stifel
Stifel more positive on Semi Cap Equipment, upgrades Lam to Buy
09/20/20 Stifel
Lam Research upgraded to Buy from Hold at Stifel
07/30/20 Wells Fargo
Lam Research price target raised to $370 from $270 at Wells Fargo
EW Edwards Lifesciences
$83.07 /

-1.43 (-1.69%)

10/19/20 Cowen
Edwards Lifesciences price target raised to $100 from $85 at Cowen
10/14/20 Piper Sandler
Edwards Lifesciences market share 'highly durable,' says Piper Sandler
09/11/20 Wolfe Research
Edwards Lifesciences initiated with an Underperform at Wolfe Research
07/24/20 SVB Leerink
Edwards Lifesciences price target raised to $95 from $90 at SVB Leerink
CMG Chipotle
$1,345.98 /

-2.91 (-0.22%)

10/20/20 Loop Capital
Chipotle price target raised to $1,600 from $1,400 at Loop Capital
10/20/20 JPMorgan
Chipotle price target raised to $1,115 from $1,040 at JPMorgan
10/19/20 RBC Capital
Chipotle price target raised to $1,320 from $1,250 at RBC Capital
10/16/20 Cleveland Research
Chipotle comp trends look improved in recent weeks, says Cleveland Research
LVS Las Vegas Sands
$46.10 /

-0.12 (-0.26%)

10/20/20 JPMorgan
Las Vegas Sands price target lowered to $50 from $57 at JPMorgan
10/20/20 Deutsche Bank
Las Vegas Sands price target lowered to $58 from $60 at Deutsche Bank
10/19/20
Fly Intel: Top five analyst downgrades
10/19/20 Union Gaming
Las Vegas Sands downgraded to Hold from Buy at Union Gaming
KMI Kinder Morgan
$12.51 /

-0.165 (-1.30%)

09:37 Today Capital One
Kinder Morgan initiated with an Equalweight at Capital One
10/14/20 Goldman Sachs
Kinder Morgan upgraded to Neutral from Sell at Goldman Sachs
07/07/20
Fly Intel: Top five analyst downgrades
07/06/20 Goldman Sachs
Kinder Morgan downgraded to Sell from Neutral at Goldman Sachs
XLNX Xilinx
$112.17 /

-2.75 (-2.39%)

10/20/20 Citi
Citi opens 'negative catalyst watch' on Xilinx, sees no AMD deal
10/16/20 RBC Capital
Xilinx price target raised to $92 from $84 at RBC Capital
10/12/20 Baird
Baird downgrades 'fully valued' Xilinx amid AMD deal speculation
10/12/20 Baird
Xilinx downgraded to Neutral from Outperform at Baird
ALGN Align Technology
$334.03 /

-1.02 (-0.30%)

10/15/20 Piper Sandler
Piper names Align Technology top pick, boosts target to $400 from $345
07/29/20 Craig-Hallum
SmileDirectClub teen program should have immediate impact, says Craig-Hallum
07/29/20 Berenberg
Align Technology downgraded to Hold from Buy at Berenberg
07/23/20 Barclays
Align Technology downgraded to Equal Weight from Overweight at Barclays
EFX Equifax
$162.59 /

+2.78 (+1.74%)

10/07/20 Exane BNP Paribas
Equifax upgraded to Outperform from Neutral at Exane BNP Paribas
10/06/20
Fly Intel: Top five analyst initiations
10/06/20 Needham
Equifax initiated with a Buy at Needham
10/06/20 Needham
Equifax initiated with a Buy at Needham
DFS Discover
$61.21 /

-1.75 (-2.78%)

10/09/20 JPMorgan
Discover price target raised to $70 from $54.50 at JPMorgan
10/05/20 Goldman Sachs
Discover price target raised to $76 from $68 at Goldman Sachs
07/31/20 Wolfe Research
Discover initiated with an Outperform at Wolfe Research
07/24/20 Stephens
Discover price target raised to $62 from $42 at Stephens
SLM Sallie Mae
$9.34 /

-0.1 (-1.06%)

10/09/20 JPMorgan
Sallie Mae price target raised to $9 from $7.50 at JPMorgan
07/15/20 JPMorgan
Sallie Mae downgraded to Neutral on rising delinquencies at JPMorgan
07/15/20 JPMorgan
Sallie Mae downgraded to Neutral from Overweight at JPMorgan
05/14/20 BMO Capital
BMO downgrades Sallie Mae amid college opening, election uncertainty
STL Sterling Bancorp
$12.27 /

-0.035 (-0.28%)

01/09/20 B. Riley FBR
Axos, Meta Financial among FBR's top Banks & Thrifts picks for 2020
01/02/20 Stephens
Stephens releases Best Ideas list for 2020
10/28/19 Stephens
Sterling Bancorp resumed with an Overweight at Stephens
TSLA Tesla
$428.60 /

+6.63 (+1.57%)

CSX CSX
$79.02 /

-1.13 (-1.41%)

LRCX Lam Research
$368.57 /

+4.72 (+1.30%)

EW Edwards Lifesciences
$83.07 /

-1.43 (-1.69%)

CMG Chipotle
$1,345.98 /

-2.91 (-0.22%)

LVS Las Vegas Sands
$46.10 /

-0.12 (-0.26%)

KMI Kinder Morgan
$12.51 /

-0.165 (-1.30%)

XLNX Xilinx
$112.17 /

-2.75 (-2.39%)

ALGN Align Technology
$334.03 /

-1.02 (-0.30%)

EFX Equifax
$162.59 /

+2.78 (+1.74%)

DFS Discover
$61.21 /

-1.75 (-2.78%)

SLM Sallie Mae
$9.34 /

-0.1 (-1.06%)

STL Sterling Bancorp
$12.27 /

-0.035 (-0.28%)

  • 14
    Feb
TSLA Tesla
$428.60 /

+6.63 (+1.57%)

LRCX Lam Research
$368.57 /

+4.72 (+1.30%)

CMG Chipotle
$1,345.98 /

-2.91 (-0.22%)

LVS Las Vegas Sands
$46.10 /

-0.12 (-0.26%)

KMI Kinder Morgan
$12.51 /

-0.165 (-1.30%)

XLNX Xilinx
$112.17 /

-2.75 (-2.39%)

EFX Equifax
$162.59 /

+2.78 (+1.74%)

DFS Discover
$61.21 /

-1.75 (-2.78%)

TSLA Tesla
$428.60 /

+6.63 (+1.57%)

CSX CSX
$79.02 /

-1.13 (-1.41%)

LRCX Lam Research
$368.57 /

+4.72 (+1.30%)

EW Edwards Lifesciences
$83.07 /

-1.43 (-1.69%)

CMG Chipotle
$1,345.98 /

-2.91 (-0.22%)

LVS Las Vegas Sands
$46.10 /

-0.12 (-0.26%)

KMI Kinder Morgan
$12.51 /

-0.165 (-1.30%)

XLNX Xilinx
$112.17 /

-2.75 (-2.39%)

ALGN Align Technology
$334.03 /

-1.02 (-0.30%)

EFX Equifax
$162.59 /

+2.78 (+1.74%)

DFS Discover
$61.21 /

-1.75 (-2.78%)

SLM Sallie Mae
$9.34 /

-0.1 (-1.06%)

TSLA Tesla
$428.60 /

+6.63 (+1.57%)

CSX CSX
$79.02 /

-1.13 (-1.41%)

LRCX Lam Research
$368.57 /

+4.72 (+1.30%)

CMG Chipotle
$1,345.98 /

-2.91 (-0.22%)

LVS Las Vegas Sands
$46.10 /

-0.12 (-0.26%)

KMI Kinder Morgan
$12.51 /

-0.165 (-1.30%)

XLNX Xilinx
$112.17 /

-2.75 (-2.39%)

EFX Equifax
$162.59 /

+2.78 (+1.74%)

DFS Discover
$61.21 /

-1.75 (-2.78%)

SLM Sallie Mae
$9.34 /

-0.1 (-1.06%)

On The Fly
Fly Intel: What to watch in Tesla earnings report » 12:05
10/21/20
10/21
12:05
10/21/20
12:05
TSLA

Tesla

$431.48 /

+9.51 (+2.25%)

, PCRFY

Panasonic

$0.00 /

+ (+0.00%)

Tesla (TSLA) is expected…

ShowHide Related Items >><<
TSLA Tesla
$431.48 /

+9.51 (+2.25%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$431.48 /

+9.51 (+2.25%)

10/19/20 Wedbush
Tesla price target raised to $500 from $475 at Wedbush
10/16/20 Morgan Stanley
Tesla price target raised to $333 from $272 at Morgan Stanley
10/14/20 Credit Suisse
Q3 beat could be positive catalyst for Tesla stock, says Credit Suisse
10/14/20 JPMorgan
NIO Inc. upgraded to Overweight from Neutral at JPMorgan
PCRFY Panasonic
$0.00 /

+ (+0.00%)

09/23/20 Jefferies
Panasonic downgraded to Underperform ahead of Tesla event at Jefferies
09/22/20 Jefferies
Panasonic downgraded to Underperform from Hold at Jefferies
04/22/20 UBS
Panasonic downgraded to Sell from Neutral at UBS
03/16/20 Citi
Panasonic upgraded to Buy from Neutral at Citi
TSLA Tesla
$431.48 /

+9.51 (+2.25%)

  • 14
    Feb
TSLA Tesla
$431.48 /

+9.51 (+2.25%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$431.48 /

+9.51 (+2.25%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$431.48 /

+9.51 (+2.25%)

On The Fly
Pinterest jumps as analysts say buy after Snap earnings beat » 11:14
10/21/20
10/21
11:14
10/21/20
11:14
PINS

Pinterest

$50.09 /

+4.78 (+10.55%)

, SNAP

Snap

$38.11 /

+9.67 (+34.00%)

, TWTR

Twitter

$49.41 /

+3.06 (+6.60%)

Shares of Pinterest…

ShowHide Related Items >><<
TWTR Twitter
$49.41 /

+3.06 (+6.60%)

SNAP Snap
$38.11 /

+9.67 (+34.00%)

PINS Pinterest
$50.09 /

+4.78 (+10.55%)

PINS Pinterest
$50.09 /

+4.78 (+10.55%)

09:54 Today
Fly Intel: Top five analyst upgrades
07:08 Today Goldman Sachs
Pinterest upgraded to Buy from Neutral at Goldman Sachs
06:39 Today BofA
Pinterest upgraded to Buy from Neutral at BofA
10/20/20 Credit Suisse
Pinterest price target raised to $36 from $31 at Credit Suisse
SNAP Snap
$38.11 /

+9.67 (+34.00%)

09:23 Today MKM Partners
Snap price target raised to $40 from $29 at MKM Partners
09:10 Today RBC Capital
Snap price target raised to $45 from $28 at RBC Capital
08:51 Today Truist
Snap upgraded to Buy from Hold at Truist
TWTR Twitter
$49.41 /

+3.06 (+6.60%)

10/20/20 Jefferies
Twitter price target raised to $46 from $39 at Jefferies
10/15/20 Cowen
Trump unhappiness may reinforce odds of antitrust action on Facebook, says Cowen
10/12/20
Fly Intel: Top five analyst upgrades
TWTR Twitter
$49.41 /

+3.06 (+6.60%)

SNAP Snap
$38.11 /

+9.67 (+34.00%)

PINS Pinterest
$50.09 /

+4.78 (+10.55%)

TWTR Twitter
$49.41 /

+3.06 (+6.60%)

SNAP Snap
$38.11 /

+9.67 (+34.00%)

PINS Pinterest
$50.09 /

+4.78 (+10.55%)

TWTR Twitter
$49.41 /

+3.06 (+6.60%)

SNAP Snap
$38.11 /

+9.67 (+34.00%)

PINS Pinterest
$50.09 /

+4.78 (+10.55%)

TWTR Twitter
$49.41 /

+3.06 (+6.60%)

SNAP Snap
$38.11 /

+9.67 (+34.00%)

PINS Pinterest
$50.09 /

+4.78 (+10.55%)

On The Fly
Snap, Pinterest upgrades among today's top calls on Wall Street » 10:01
10/21/20
10/21
10:01
10/21/20
10:01
SNAP

Snap

$35.88 /

+7.44 (+26.16%)

, PINS

Pinterest

$50.54 /

+5.23 (+11.54%)

, TWTR

Twitter

$49.67 /

+3.32 (+7.16%)

, WORK

Slack Technologies

$29.18 /

-1.64 (-5.32%)

, MSFT

Microsoft

$215.25 /

+0.74 (+0.34%)

, ZM

Zoom Video

$549.00 /

+12.055 (+2.25%)

, GOOG

Alphabet

$1,604.93 /

+50.02 (+3.22%)

, GOOGL

Alphabet Class A

$1,602.85 /

+51.88 (+3.35%)

, DGX

Quest Diagnostics

$124.25 /

+0.82 (+0.66%)

, PAYC

Paycom

$386.25 /

+1.46 (+0.38%)

Check out today's top…

ShowHide Related Items >><<
ZM Zoom Video
$549.00 /

+12.055 (+2.25%)

WORK Slack Technologies
$29.18 /

-1.64 (-5.32%)

TWTR Twitter
$49.67 /

+3.32 (+7.16%)

SNAP Snap
$35.88 /

+7.44 (+26.16%)

PINS Pinterest
$50.54 /

+5.23 (+11.54%)

PAYC Paycom
$386.25 /

+1.46 (+0.38%)

MSFT Microsoft
$215.25 /

+0.74 (+0.34%)

GOOG Alphabet
$1,604.93 /

+50.02 (+3.22%)

DGX Quest Diagnostics
$124.25 /

+0.82 (+0.66%)

SNAP Snap
$35.88 /

+7.44 (+26.16%)

09:54 Today
Fly Intel: Top five analyst upgrades
09:23 Today MKM Partners
Snap price target raised to $40 from $29 at MKM Partners
09:10 Today RBC Capital
Snap price target raised to $45 from $28 at RBC Capital
08:51 Today Truist
Snap upgraded to Buy from Hold at Truist
PINS Pinterest
$50.54 /

+5.23 (+11.54%)

07:08 Today Goldman Sachs
Pinterest upgraded to Buy from Neutral at Goldman Sachs
06:39 Today BofA
Pinterest upgraded to Buy from Neutral at BofA
10/20/20 Credit Suisse
Pinterest price target raised to $36 from $31 at Credit Suisse
TWTR Twitter
$49.67 /

+3.32 (+7.16%)

10/20/20 Jefferies
Twitter price target raised to $46 from $39 at Jefferies
10/15/20 Cowen
Trump unhappiness may reinforce odds of antitrust action on Facebook, says Cowen
10/12/20
Fly Intel: Top five analyst upgrades
WORK Slack Technologies
$29.18 /

-1.64 (-5.32%)

09:54 Today
Fly Intel: Top five analyst downgrades
06:47 Today Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
05:16 Today Morgan Stanley
Slack downgraded to Underweight from Equal Weight at Morgan Stanley
10/14/20 RBC Capital
Slack Technologies price target raised to $37 from $30 at RBC Capital
MSFT Microsoft
$215.25 /

+0.74 (+0.34%)

10/20/20 Stifel
Microsoft price target raised to $245 from $220 at Stifel
10/20/20 Wedbush
Wedbush expects cloud strength to continue for Microsoft in September quarter
10/19/20 Jefferies
Microsoft price target raised to $260 from $240 at Jefferies
ZM Zoom Video
$549.00 /

+12.055 (+2.25%)

10/15/20 Morgan Stanley
Zoom Video meeting had 'no thesis changing announcements,' says Morgan Stanley
10/15/20 Bernstein
Zoom Video price target raised to $611 from $228 at Bernstein
10/15/20 BTIG
Zoom Video price target raised to $550 from $500 at BTIG
GOOG Alphabet
$1,604.93 /

+50.02 (+3.22%)

08:32 Today JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/20/20 Jefferies
Alphabet price target raised to $1,850 from $1,800 at Jefferies
10/19/20 Morgan Stanley
ADT Inc. price target lowered to $10 from $17 at Morgan Stanley
GOOGL Alphabet Class A
$1,602.85 /

+51.88 (+3.35%)

10/20/20 Credit Suisse
Google Search should see sharper cyclical recovery, says Credit Suisse
DGX Quest Diagnostics
$124.25 /

+0.82 (+0.66%)

07:35 Today Argus
Quest Diagnostics upgraded to Buy from Hold at Argus
07:27 Today Argus
Quest Diagnostics upgraded to Buy from Hold at Argus
10/16/20 Baird
Baird 'pounding the table' on lab stocks after 'favorable' CMS update
10/14/20 Jefferies
Quest Diagnostics price target raised to $134 from $125 at Jefferies
PAYC Paycom
$386.25 /

+1.46 (+0.38%)

06:22 Today RBC Capital
Paycom upgraded to Outperform from Sector Perform at RBC Capital
10/09/20 Barclays
Paycom price target raised to $350 from $277 at Barclays
10/08/20 Oppenheimer
Paycom price target raised to $405 from $345 at Oppenheimer
ZM Zoom Video
$549.00 /

+12.055 (+2.25%)

WORK Slack Technologies
$29.18 /

-1.64 (-5.32%)

TWTR Twitter
$49.67 /

+3.32 (+7.16%)

SNAP Snap
$35.88 /

+7.44 (+26.16%)

PINS Pinterest
$50.54 /

+5.23 (+11.54%)

PAYC Paycom
$386.25 /

+1.46 (+0.38%)

MSFT Microsoft
$215.25 /

+0.74 (+0.34%)

GOOG Alphabet
$1,604.93 /

+50.02 (+3.22%)

DGX Quest Diagnostics
$124.25 /

+0.82 (+0.66%)

ZM Zoom Video
$549.00 /

+12.055 (+2.25%)

WORK Slack Technologies
$29.18 /

-1.64 (-5.32%)

TWTR Twitter
$49.67 /

+3.32 (+7.16%)

SNAP Snap
$35.88 /

+7.44 (+26.16%)

PINS Pinterest
$50.54 /

+5.23 (+11.54%)

MSFT Microsoft
$215.25 /

+0.74 (+0.34%)

GOOG Alphabet
$1,604.93 /

+50.02 (+3.22%)

DGX Quest Diagnostics
$124.25 /

+0.82 (+0.66%)

ZM Zoom Video
$549.00 /

+12.055 (+2.25%)

WORK Slack Technologies
$29.18 /

-1.64 (-5.32%)

TWTR Twitter
$49.67 /

+3.32 (+7.16%)

SNAP Snap
$35.88 /

+7.44 (+26.16%)

PINS Pinterest
$50.54 /

+5.23 (+11.54%)

PAYC Paycom
$386.25 /

+1.46 (+0.38%)

MSFT Microsoft
$215.25 /

+0.74 (+0.34%)

GOOG Alphabet
$1,604.93 /

+50.02 (+3.22%)

DGX Quest Diagnostics
$124.25 /

+0.82 (+0.66%)

ZM Zoom Video
$549.00 /

+12.055 (+2.25%)

WORK Slack Technologies
$29.18 /

-1.64 (-5.32%)

TWTR Twitter
$49.67 /

+3.32 (+7.16%)

SNAP Snap
$35.88 /

+7.44 (+26.16%)

PINS Pinterest
$50.54 /

+5.23 (+11.54%)

MSFT Microsoft
$215.25 /

+0.74 (+0.34%)

GOOGL Alphabet Class A
$1,602.85 /

+51.88 (+3.35%)

DGX Quest Diagnostics
$124.25 /

+0.82 (+0.66%)

MSFT Microsoft
$215.25 /

+0.74 (+0.34%)

Conference/Events
Roth Capital to hold a webinar » 09:54
10/21/20
10/21
09:54
10/21/20
09:54
TSLA

Tesla

$429.52 /

+7.55 (+1.79%)

Sustainability Analyst…

Sustainability Analyst Irwin, along with Ionel Stefan, PhD, CTO of Amprius Technologies, discuss the status of silicon anode battery technology and its applicability to electric vehicles and whether Tesla is the leader in this emerging technology in a webinar entitled, "Battery Technology: Silicon Anodes--Is Tesla the Leader Here" to be held on October 23 at 11 am.

ShowHide Related Items >><<
TSLA Tesla
$429.52 /

+7.55 (+1.79%)

TSLA Tesla
$429.52 /

+7.55 (+1.79%)

10/19/20 Wedbush
Tesla price target raised to $500 from $475 at Wedbush
10/16/20 Morgan Stanley
Tesla price target raised to $333 from $272 at Morgan Stanley
10/14/20 Credit Suisse
Q3 beat could be positive catalyst for Tesla stock, says Credit Suisse
10/14/20 JPMorgan
NIO Inc. upgraded to Overweight from Neutral at JPMorgan
TSLA Tesla
$429.52 /

+7.55 (+1.79%)

  • 14
    Feb
TSLA Tesla
$429.52 /

+7.55 (+1.79%)

TSLA Tesla
$429.52 /

+7.55 (+1.79%)

TSLA Tesla
$429.52 /

+7.55 (+1.79%)

Hot Stocks
PTC Therapeutics: Evrysdi approved in Brazil for treatment of SMA » 08:35
10/21/20
10/21
08:35
10/21/20
08:35
PTCT

PTC Therapeutics

$51.40 /

-0.72 (-1.38%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

PTC Therapeutics (PTCT)…

PTC Therapeutics (PTCT) tannounced that Evrysdi was approved in Brazil by the National Health Surveillance Agency for the treatment of spinal muscular atrophy. The approval was obtained within seven months of Roche's (RHHBY) initial submission and marks the second country to approve Evrysdi. Additionally, PTC announced the filing of a New Drug Application for Evrysdi for the treatment of SMA with the Japanese Ministry of Health, Labor and Welfare. The filing in Japan by Chugai Pharmaceutical Co. Ltd., a member of the Roche group, triggers a $7.5M milestone payment to PTC from Roche.

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$51.40 /

-0.72 (-1.38%)

PTCT PTC Therapeutics
$51.40 /

-0.72 (-1.38%)

10/07/20 JPMorgan
PTC Therapeutics upgraded to Overweight with $71 target at JPMorgan
10/07/20 JPMorgan
PTC Therapeutics upgraded to Overweight from Neutral at JPMorgan
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/24/20 Raymond James
PTC Therapeutics initiated with an Outperform at Raymond James
RHHBY Roche
$0.00 /

+ (+0.00%)

10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
09/28/20 Societe Generale
Roche price target raised to CHF 420 from CHF 365 at Societe Generale
RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$51.40 /

-0.72 (-1.38%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$51.40 /

-0.72 (-1.38%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$51.40 /

-0.72 (-1.38%)

Periodicals
JPMorgan's QuickAccept service takes on Square, PayPal, CNBC reports » 07:52
10/21/20
10/21
07:52
10/21/20
07:52
JPM

JPMorgan

$100.36 /

+0.545 (+0.55%)

, SQ

Square

$185.72 /

-1.155 (-0.62%)

, PYPL

PayPal

$201.99 /

+1.91 (+0.95%)

JPMorgan's (JPM) new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$185.72 /

-1.155 (-0.62%)

PYPL PayPal
$201.99 /

+1.91 (+0.95%)

JPM JPMorgan
$100.36 /

+0.545 (+0.55%)

JPM JPMorgan
$100.36 /

+0.545 (+0.55%)

10/14/20 BMO Capital
JPMorgan price target raised to $119 from $117 at BMO Capital
10/14/20 Baird
JPMorgan should be bought on pullbacks, says Baird
09/21/20 Wells Fargo
Money laundering headlines creating extra headline risk for banks, says Wells
09/17/20 RBC Capital
JPMorgan price target raised to $110 from $99 at RBC Capital
SQ Square
$185.72 /

-1.155 (-0.62%)

06:29 Today Barclays
Square price target raised to $215 from $185 at Barclays
10/16/20 RBC Capital
Square price target raised to $240 from $200 at RBC Capital
10/05/20 Susquehanna
Square price target raised to $195 from $180 at Susquehanna
10/05/20 Barclays
Square price target raised to $185 from $170 at Barclays
PYPL PayPal
$201.99 /

+1.91 (+0.95%)

06:27 Today Barclays
PayPal price target raised to $235 from $228 at Barclays
10/19/20 Mizuho
PayPal price target raised to $290 from $285 at Mizuho
10/13/20 Susquehanna
PayPal price target raised to $235 from $220 at Susquehanna
10/08/20 KeyBanc
Digital acceleration thesis may accelerate MT FinTech initiatives, says KeyBanc
SQ Square
$185.72 /

-1.155 (-0.62%)

PYPL PayPal
$201.99 /

+1.91 (+0.95%)

JPM JPMorgan
$100.36 /

+0.545 (+0.55%)

SQ Square
$185.72 /

-1.155 (-0.62%)

PYPL PayPal
$201.99 /

+1.91 (+0.95%)

JPM JPMorgan
$100.36 /

+0.545 (+0.55%)

SQ Square
$185.72 /

-1.155 (-0.62%)

PYPL PayPal
$201.99 /

+1.91 (+0.95%)

JPM JPMorgan
$100.36 /

+0.545 (+0.55%)

SQ Square
$185.72 /

-1.155 (-0.62%)

PYPL PayPal
$201.99 /

+1.91 (+0.95%)

JPM JPMorgan
$100.36 /

+0.545 (+0.55%)

Upgrade
Pinterest upgraded to Buy from Neutral at Goldman Sachs » 07:08
10/21/20
10/21
07:08
10/21/20
07:08
PINS

Pinterest

$45.28 /

-0.54 (-1.18%)

, SNAP

Snap

$28.44 /

-0.215 (-0.75%)

, TWTR

Twitter

$46.35 /

+0.54 (+1.18%)

Goldman Sachs analyst…

Goldman Sachs analyst Heath Terry upgraded Pinterest (PINS) to Buy from Neutral with a price target of $61, up from $37. Based on current app download data, Pinterest's "strong" user growth continued through Q3, Terry tells investors in a research note. Feld checks, along with Snap's (SNAP) Q3 results, suggest that advertiser demand strengthened over the course of the quarter, particularly for smaller platforms like Pinterest, Twitter (TWTR), and Snap, says the analyst. Terry believes Pinterest's long term monetization opportunity should drive further outperformance of the shares given the "early stage nature" of the company's advertising technology and sales investments, particularly outside the U.S.

ShowHide Related Items >><<
TWTR Twitter
$46.35 /

+0.54 (+1.18%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

PINS Pinterest
$45.28 /

-0.54 (-1.18%)

PINS Pinterest
$45.28 /

-0.54 (-1.18%)

06:39 Today BofA
Pinterest upgraded to Buy from Neutral at BofA
10/20/20 Credit Suisse
Pinterest price target raised to $36 from $31 at Credit Suisse
10/16/20 Wells Fargo
Pinterest price target raised to $52 from $40 at Wells Fargo
SNAP Snap
$28.44 /

-0.215 (-0.75%)

07:02 Today Deutsche Bank
Snap price target raised to $40 from $32 at Deutsche Bank
06:28 Today Barclays
Snap price target raised to $42 from $29 at Barclays
06:10 Today JMP Securities
Snap price target raised to $40 from $28 at JMP Securities
TWTR Twitter
$46.35 /

+0.54 (+1.18%)

10/20/20 Jefferies
Twitter price target raised to $46 from $39 at Jefferies
10/15/20 Cowen
Trump unhappiness may reinforce odds of antitrust action on Facebook, says Cowen
10/12/20
Fly Intel: Top five analyst upgrades
10/12/20 Deutsche Bank
Deutsche upgrades Twitter to Buy on 'compelling bull case' for 2021
TWTR Twitter
$46.35 /

+0.54 (+1.18%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

PINS Pinterest
$45.28 /

-0.54 (-1.18%)

TWTR Twitter
$46.35 /

+0.54 (+1.18%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

PINS Pinterest
$45.28 /

-0.54 (-1.18%)

TWTR Twitter
$46.35 /

+0.54 (+1.18%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

PINS Pinterest
$45.28 /

-0.54 (-1.18%)

TWTR Twitter
$46.35 /

+0.54 (+1.18%)

SNAP Snap
$28.44 /

-0.215 (-0.75%)

PINS Pinterest
$45.28 /

-0.54 (-1.18%)

Conference/Events
American Society of Nephrology to hold virtual annual meeting » 04:55
10/21/20
10/21
04:55
10/21/20
04:55
AKBA

Akebia

$3.56 /

-0.14 (-3.78%)

, ALNY

Alnylam

$141.42 /

+0.82 (+0.58%)

, ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

, AMGN

Amgen

$231.14 /

+0.29 (+0.13%)

, AZN

AstraZeneca

$52.18 /

-0.26 (-0.50%)

, BAX

Baxter

$81.25 /

+0.05 (+0.06%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BD

Budget Group

$0.00 /

+ (+0.00%)

, CALT

Calliditas Therapeutics

$27.57 /

-0.14 (-0.51%)

, ICUI

ICU Medical

$190.81 /

-0.26 (-0.14%)

, TCDA

Tricida

$8.82 /

-0.185 (-2.05%)

, SNY

Sanofi

$49.96 /

-0.21 (-0.42%)

, GSK

GlaxoSmithKline

$36.04 /

-0.14 (-0.39%)

, FOLD

Amicus

$16.97 /

+0.12 (+0.71%)

, FMS

Fresenius Medical

$39.85 /

-1.62 (-3.91%)

, DRNA

Dicerna

$19.17 /

-0.88 (-4.39%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, CCXI

ChemoCentryx

$53.44 /

-0.19 (-0.35%)

, KDNY

Chinook Therapeutics

$16.73 /

+0.57 (+3.53%)

, RTRX

Retrophin

$20.89 /

-0.45 (-2.11%)

, OMER

Omeros

$11.26 /

+0.2 (+1.81%)

, OM

Outset Medical

$46.38 /

-1.85 (-3.84%)

, NVS

Novartis

$85.75 /

-0.02 (-0.02%)

, VRTX

Vertex Pharmaceuticals

$214.65 /

-6.06 (-2.75%)

Kidney Week 2020: Virtual…

Kidney Week 2020: Virtual Annual Meeting will be held on October 19-25. Webcast Link

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$214.65 /

-6.06 (-2.75%)

TCDA Tricida
$8.82 /

-0.185 (-2.05%)

SNY Sanofi
$49.96 /

-0.21 (-0.42%)

RTRX Retrophin
$20.89 /

-0.45 (-2.11%)

OMER Omeros
$11.26 /

+0.2 (+1.81%)

NVS Novartis
$85.75 /

-0.02 (-0.02%)

KDNY Chinook Therapeutics
$16.73 /

+0.57 (+3.53%)

ICUI ICU Medical
$190.81 /

-0.26 (-0.14%)

GSK GlaxoSmithKline
$36.04 /

-0.14 (-0.39%)

FOLD Amicus
$16.97 /

+0.12 (+0.71%)

FMS Fresenius Medical
$39.85 /

-1.62 (-3.91%)

DRNA Dicerna
$19.17 /

-0.88 (-4.39%)

CCXI ChemoCentryx
$53.44 /

-0.19 (-0.35%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.25 /

+0.05 (+0.06%)

AZN AstraZeneca
$52.18 /

-0.26 (-0.50%)

AMGN Amgen
$231.14 /

+0.29 (+0.13%)

ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

ALNY Alnylam
$141.42 /

+0.82 (+0.58%)

AKBA Akebia
$3.56 /

-0.14 (-3.78%)

AKBA Akebia
$3.56 /

-0.14 (-3.78%)

09/04/20 RBC Capital
Akebia price target lowered to $5 from $12 at RBC Capital
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
09/04/20 BTIG
Akebia price target lowered to $6 from $26 at BTIG
09/04/20 Mizuho
Akebia price target lowered to $6 from $17 at Mizuho
ALNY Alnylam
$141.42 /

+0.82 (+0.58%)

09/30/20 Berenberg
Alnylam reinitiated with a Hold at Berenberg
09/08/20 Citi
Alnylam initiated with a Buy at Citi
08/11/20 Oppenheimer
Alnylam downgraded to Perform on valuation at Oppenheimer
08/11/20 Oppenheimer
Alnylam downgraded to Perform from Outperform at Oppenheimer
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
AMGN Amgen
$231.14 /

+0.29 (+0.13%)

10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
AZN AstraZeneca
$52.18 /

-0.26 (-0.50%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
BAX Baxter
$81.25 /

+0.05 (+0.06%)

10/08/20 Goldman Sachs
Baxter pump delays speak more to FDA protocols than actual product, says Goldman
10/08/20 Piper Sandler
Baxter 510k submission withdrawal 'disappointing,' 'not surprising,' says Piper
10/08/20 KeyBanc
Investors will view Baxter pump news 'somewhat negatively,' says KeyBanc
10/01/20
Fly Intel: Top five analyst upgrades
BAYRY Bayer
$0.00 /

+ (+0.00%)

10/13/20 Barclays
Bayer downgraded to Equal Weight from Overweight at Barclays
10/08/20 Kepler Cheuvreux
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
10/05/20 UBS
Bayer price target lowered to EUR 85 from EUR 110 at UBS
10/02/20 Deutsche Bank
Bayer price target lowered to EUR 64 from EUR 82 at Deutsche Bank
BD Budget Group
$0.00 /

+ (+0.00%)

CALT Calliditas Therapeutics
$27.57 /

-0.14 (-0.51%)

07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
ICUI ICU Medical
$190.81 /

-0.26 (-0.14%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
03/18/20 KeyBanc
ICU Medical upgraded to Overweight from Sector Weight at KeyBanc
11/12/19 Raymond James
ICU Medical price target raised to $203 from $185 at Raymond James
TCDA Tricida
$8.82 /

-0.185 (-2.05%)

09/29/20 JPMorgan
Tricida resumed with an Underweight at JPMorgan
08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Needham
Tricida price target lowered to $20 from $44 at Needham
08/25/20 Goldman Sachs
Tricida downgraded to Neutral from Buy at Goldman Sachs
SNY Sanofi
$49.96 /

-0.21 (-0.42%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
GSK GlaxoSmithKline
$36.04 /

-0.14 (-0.39%)

10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
10/09/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,695 GBp from 1,700 GBp at Morgan Stanley
10/08/20 JPMorgan
JPMorgan backs Neutral on GSK ahead of Q3 results
FOLD Amicus
$16.97 /

+0.12 (+0.71%)

08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
FMS Fresenius Medical
$39.85 /

-1.62 (-3.91%)

10/13/20 Deutsche Bank
Fresenius Medical price target lowered to EUR 97 from EUR 100 at Deutsche Bank
08/18/20 Morgan Stanley
Fresenius Medical price target raised to EUR 76 from EUR 70 at Morgan Stanley
08/05/20 Jefferies
Fresenius Medical downgraded to Hold from Buy at Jefferies
07/28/20 Berenberg
Fresenius Medical price target raised to EUR 94.85 from EUR 88.25 at Berenberg
DRNA Dicerna
$19.17 /

-0.88 (-4.39%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
DNA Bought by RHHBY
$0.00 /

+ (+0.00%)

CCXI ChemoCentryx
$53.44 /

-0.19 (-0.35%)

09/17/20 H.C. Wainwright
ChemoCentryx price target raised to $85 from $73 at H.C. Wainwright
09/17/20 Piper Sandler
ChemoCentryx target lowered to $67 at Piper Sandler on lower avacopan AAV sales
08/12/20 SVB Leerink
ChemoCentryx price target raised to $75 from $65 at SVB Leerink
07/09/20 Piper Sandler
ChemoCentryx submits NDA for avacopan in AAV to FDA, says Piper Sandler
KDNY Chinook Therapeutics
$16.73 /

+0.57 (+3.53%)

10/20/20 Oppenheimer
Chinook Therapeutics upgraded to Outperform from Perform at Oppenheimer
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
RTRX Retrophin
$20.89 /

-0.45 (-2.11%)

09/17/20 Wedbush
Wedbush starts Retrophin at Outperform ahead of 'value-creating catalysts'
09/17/20 Wedbush
Retrophin initiated with an Outperform at Wedbush
08/24/20 BofA
Retrophin initiated with a Buy at BofA
07/13/20 BMO Capital
Retrophin price target lowered to $31 from $34 at BMO Capital
OMER Omeros
$11.26 /

+0.2 (+1.81%)

10/20/20 BofA
Omeros initiated with a Buy at BofA
10/20/20 BofA
Omeros initiated with a Buy at BofA
09/01/20 Wedbush
Omeros price target lowered to $12 from $17 at Wedbush
08/21/20 H.C. Wainwright
Omeros price target lowered to $32 from $34 at H.C. Wainwright
OM Outset Medical
$46.38 /

-1.85 (-3.84%)

10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
10/12/20 Stifel
Outset Medical initiated with a Buy at Stifel
10/12/20 SVB Leerink
Outset Medical initiated with a Market Perform at SVB Leerink
NVS Novartis
$85.75 /

-0.02 (-0.02%)

09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
VRTX Vertex Pharmaceuticals
$214.65 /

-6.06 (-2.75%)

10/15/20 Truist
Vertex Pharmaceuticals price target lowered to $305 from $330 at Truist
10/15/20 Morgan Stanley
VX-814 discontinuation can drive Vertex shares 5%-10% lower, says Morgan Stanley
10/15/20 JPMorgan
Vertex pipeline setback a 'major disappointment,' says JPMorgan
10/15/20 Citi
Vertex selloff on VX-814 news a buying opportunity, says Citi
VRTX Vertex Pharmaceuticals
$214.65 /

-6.06 (-2.75%)

TCDA Tricida
$8.82 /

-0.185 (-2.05%)

SNY Sanofi
$49.96 /

-0.21 (-0.42%)

RTRX Retrophin
$20.89 /

-0.45 (-2.11%)

OMER Omeros
$11.26 /

+0.2 (+1.81%)

NVS Novartis
$85.75 /

-0.02 (-0.02%)

ICUI ICU Medical
$190.81 /

-0.26 (-0.14%)

GSK GlaxoSmithKline
$36.04 /

-0.14 (-0.39%)

FOLD Amicus
$16.97 /

+0.12 (+0.71%)

DRNA Dicerna
$19.17 /

-0.88 (-4.39%)

CCXI ChemoCentryx
$53.44 /

-0.19 (-0.35%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.25 /

+0.05 (+0.06%)

AZN AstraZeneca
$52.18 /

-0.26 (-0.50%)

AMGN Amgen
$231.14 /

+0.29 (+0.13%)

ALNY Alnylam
$141.42 /

+0.82 (+0.58%)

AKBA Akebia
$3.56 /

-0.14 (-3.78%)

  • 15
    Sep
  • 12
    Aug
  • 11
    Jun
  • 09
    Jun
  • 05
    Jun
  • 12
    May
  • 05
    Dec
SNY Sanofi
$49.96 /

-0.21 (-0.42%)

NVS Novartis
$85.75 /

-0.02 (-0.02%)

GSK GlaxoSmithKline
$36.04 /

-0.14 (-0.39%)

FOLD Amicus
$16.97 /

+0.12 (+0.71%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$52.18 /

-0.26 (-0.50%)

AMGN Amgen
$231.14 /

+0.29 (+0.13%)

AKBA Akebia
$3.56 /

-0.14 (-3.78%)

VRTX Vertex Pharmaceuticals
$214.65 /

-6.06 (-2.75%)

TCDA Tricida
$8.82 /

-0.185 (-2.05%)

SNY Sanofi
$49.96 /

-0.21 (-0.42%)

OMER Omeros
$11.26 /

+0.2 (+1.81%)

OM Outset Medical
$46.38 /

-1.85 (-3.84%)

NVS Novartis
$85.75 /

-0.02 (-0.02%)

GSK GlaxoSmithKline
$36.04 /

-0.14 (-0.39%)

CCXI ChemoCentryx
$53.44 /

-0.19 (-0.35%)

CALT Calliditas Therapeutics
$27.57 /

-0.14 (-0.51%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.25 /

+0.05 (+0.06%)

AZN AstraZeneca
$52.18 /

-0.26 (-0.50%)

AMGN Amgen
$231.14 /

+0.29 (+0.13%)

ALNY Alnylam
$141.42 /

+0.82 (+0.58%)

AKBA Akebia
$3.56 /

-0.14 (-3.78%)

VRTX Vertex Pharmaceuticals
$214.65 /

-6.06 (-2.75%)

SNY Sanofi
$49.96 /

-0.21 (-0.42%)

KDNY Chinook Therapeutics
$16.73 /

+0.57 (+3.53%)

GSK GlaxoSmithKline
$36.04 /

-0.14 (-0.39%)

AZN AstraZeneca
$52.18 /

-0.26 (-0.50%)

AMGN Amgen
$231.14 /

+0.29 (+0.13%)

AKBA Akebia
$3.56 /

-0.14 (-3.78%)

Yesterday
Hot Stocks
Prothena, Roche to advance prasinezumab into late-stage clinical development » 16:13
10/20/20
10/20
16:13
10/20/20
16:13
PRTA

Prothena

$11.27 /

+0.13 (+1.17%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Prothena (PRTA), a…

Prothena (PRTA), a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases, announced that based on positive signals of efficacy consistent with disease modification in the PASADENA study, Roche(RHHBY) and Prothena plan to advance prasinezumab into a Phase 2b study in patients with early Parkinson's disease. The study will be designed to further assess the efficacy of prasinezumab by expanding upon the patient population enrolled in PASADENA to include patients with early Parkinson's disease on stable levodopa therapy. Prasinezumab is the first anti-alpha synuclein antibody to advance into late-stage development. Prothena will earn a $60 million clinical milestone payment upon first patient dosed in this study. Further details are expected to be announced in the first half of 2021. "We are very encouraged by the results from PASADENA, demonstrating significant slowing of motor progression and improvements on imaging biomarkers consistent with disease modification, as this provides a rich dataset to directly inform and de-risk this next late-stage study," stated Gene Kinney, PhD, president and chief executive officer of Prothena. "Results from the PASADENA study are part of a growing clinical body of evidence suggesting antibodies that optimally target misfolded proteins can result in clinically meaningful benefit. With a growing pipeline of programs based on this scientific approach, Prothena is poised to advance a number of novel therapeutics for devastating diseases."

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

PRTA Prothena
$11.27 /

+0.13 (+1.17%)

PRTA Prothena
$11.27 /

+0.13 (+1.17%)

07/09/20 Oppenheimer
Prothena upgraded to Outperform at Oppenheimer
07/09/20 Oppenheimer
Prothena upgraded to Outperform from Perform at Oppenheimer
11/19/19 Evercore ISI
Prothena upgraded to Outperform on valuation at Evercore ISI
11/19/19 Evercore ISI
Prothena upgraded to Outperform from In Line at Evercore ISI
RHHBY Roche
$0.00 /

+ (+0.00%)

10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
09/28/20 Societe Generale
Roche price target raised to CHF 420 from CHF 365 at Societe Generale
RHHBY Roche
$0.00 /

+ (+0.00%)

PRTA Prothena
$11.27 /

+0.13 (+1.17%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PRTA Prothena
$11.27 /

+0.13 (+1.17%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.